Want to join the conversation?
David Risinger from Morgan Stanley asks about US Opdivo sequential momentum, the factors influencing 3Q16 US sales sequentially. $BMY said it's pleased with the quality of earnings in 2Q16 & expects continued strong demand in 3Q16. $BMY also continues to look to prepare the market as it focus on PD-L1 testing for the 1st line commercial execution.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.